Analyst: Salix could be acquired for $190 per share By: Triangle Business Journal via Business Journals September 29, 2014 at 14:50 PM EDT Analysts at Sterne Agee predict there is a 55 percent probability that Raleigh’s Salix Pharmaceuticals will be acquired at $190 per share... Read More >> Related Stocks: Valeant Pharmaceuticals International, Inc.
